AU1029500A - Pharmaceutical and/or diet product - Google Patents

Pharmaceutical and/or diet product

Info

Publication number
AU1029500A
AU1029500A AU10295/00A AU1029500A AU1029500A AU 1029500 A AU1029500 A AU 1029500A AU 10295/00 A AU10295/00 A AU 10295/00A AU 1029500 A AU1029500 A AU 1029500A AU 1029500 A AU1029500 A AU 1029500A
Authority
AU
Australia
Prior art keywords
pharmaceutical
diet product
diet
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10295/00A
Inventor
Mihaly Boros
Miklos Ghyczy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19839443A external-priority patent/DE19839443A1/en
Priority claimed from DE19839441A external-priority patent/DE19839441A1/en
Application filed by Individual filed Critical Individual
Publication of AU1029500A publication Critical patent/AU1029500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
AU10295/00A 1998-08-29 1999-08-27 Pharmaceutical and/or diet product Abandoned AU1029500A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE19839443A DE19839443A1 (en) 1998-08-29 1998-08-29 Pharmaceutical and dietetic product contains quaternary ammonium compound and/or S-adenosyl-methionine, useful for treatment of oxygen deficiency and energy metabolism disorders and NSAID side effects
DE19839441 1998-08-29
DE19839443 1998-08-29
DE19839441A DE19839441A1 (en) 1998-08-29 1998-08-29 Pharmaceutical and dietetic product contains quaternary ammonium compound and/or S-adenosyl-methionine, useful for treatment of oxygen deficiency and energy metabolism disorders and NSAID side effects
DE19919979 1999-04-30
DE19919979 1999-04-30
PCT/DE1999/002691 WO2000012071A2 (en) 1998-08-29 1999-08-27 Pharmaceutical and/or diet product

Publications (1)

Publication Number Publication Date
AU1029500A true AU1029500A (en) 2000-03-21

Family

ID=27218635

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10295/00A Abandoned AU1029500A (en) 1998-08-29 1999-08-27 Pharmaceutical and/or diet product

Country Status (3)

Country Link
AU (1) AU1029500A (en)
DE (1) DE19981729D2 (en)
WO (1) WO2000012071A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19959546A1 (en) * 1999-12-09 2001-06-21 Rhone Poulenc Rorer Gmbh Pharmaceutical preparation for the treatment of tumor diseases
ITMI20012462A1 (en) 2001-11-22 2003-05-22 Gnosis Srl PROCESS FOR THE PREPARATION OF TABS INCLUDING S-ADENOSYLMETHIONINE
US9901574B2 (en) 2015-04-20 2018-02-27 Tolero Pharmaceuticals, Inc. Predicting response to alvocidib by mitochondrial profiling
CN111349118B (en) 2015-05-18 2023-08-22 住友制药肿瘤公司 Avicenna prodrugs with increased bioavailability
CA2993659A1 (en) 2015-08-03 2017-02-09 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
WO2019055579A1 (en) 2017-09-12 2019-03-21 Tolero Pharmaceuticals, Inc. Treatment regimen for cancers that are insensitive to bcl-2 inhibitors using the mcl-1 inhibitor alvocidib
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
JP2022525149A (en) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
CA3164206A1 (en) * 2019-12-16 2021-06-24 Hill's Pet Nutrition, Inc. Pet food compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759980A (en) * 1969-05-26 1973-09-18 Stockton Chemicals Inc Salicylates
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
EP0092121B1 (en) * 1982-04-12 1987-12-16 Board Of Regents, The University Of Texas System Methods and compositions for treating gastro-intestinal ulcer diesease
GB8325627D0 (en) * 1983-09-24 1983-10-26 Scras Therapeutic compositions
WO1988003797A1 (en) * 1986-11-28 1988-06-02 The Liposome Company, Inc. Phospholipid composition
FR2630346B1 (en) * 1988-04-22 1991-03-22 Dubois Jacques NOVEL PRODUCTS COMPRISING AN EMULSION OF WATER AND OILY PARAFFINIC HYDROCARBONS WITH LECITHIN EXTRACTS AND MANUFACTURING METHODS
EP0514576A1 (en) * 1991-05-24 1992-11-25 Societe Des Produits Nestle S.A. Oil-soluble antioxidant mixture
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
DE4405545A1 (en) * 1994-02-22 1995-08-31 Dietl Hans Oral vitamin compsn. with improved resorption

Also Published As

Publication number Publication date
WO2000012071A2 (en) 2000-03-09
DE19981729D2 (en) 2001-08-09
WO2000012071A3 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU6503299A (en) High-beta-conglycinin products and their use
AU5040598A (en) Cereal product containing probiotics
AU3173095A (en) Novel pharmaceutical product
AU3782897A (en) Anti-stress drugs and functional foods having anti-stress effects
AU2312300A (en) Processing product components
GB9610862D0 (en) Pharmaceutical products
GB9801538D0 (en) Pharmaceutical product
AU4387497A (en) Jellying product
AUPP466598A0 (en) Product and process
AU2543399A (en) Anticonvulsant drugs and pharmaceutical compositions thereof
AU1409100A (en) Drugs
AU5204098A (en) Food product
AU6213699A (en) Nutritional and pharmaceutical compositions
AU1029500A (en) Pharmaceutical and/or diet product
AU3198299A (en) Multi-carotenoid product
AU1904097A (en) Food product
GB9802088D0 (en) Pharmaceutical products
AU6516298A (en) Kombucha products and processes for the preparation thereof
AU1064800A (en) Products and methods
GB9619894D0 (en) Pharmaceutical products
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU1670800A (en) 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
AU2231899A (en) Pudding preparation and products
AU4834799A (en) Human az-1 gene, variants thereof and expressed gene products
AUPP409798A0 (en) Edible products and formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase